Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:hasAssay |
gptkb:Homo_sapiens
binding assay |
| gptkbp:hasBiologicalActivity |
inhibitor
|
| gptkbp:hasInChIKey |
QZJZQKQJQJQJQJ-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C17H19N3O3S
|
| gptkbp:hasSMILES |
CN1C=CC2=C1C=CC(=C2)C3=CC(=O)NC(=O)C3C4=CC(=C(C=C4)Cl)Cl
|
| gptkbp:hasStandardType |
IC50
|
| gptkbp:hasStandardValue |
0.013 μM
|
| gptkbp:molecularWeight |
345.42
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL1201197
|
| gptkbp:supportsDatabase |
gptkb:ChEMBL
|
| gptkbp:synonym |
gptkb:GSK-3_inhibitor_VIII
gptkb:3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione |
| gptkbp:target |
gptkb:glycogen_synthase_kinase-3_beta
|
| gptkbp:bfsParent |
gptkb:temsirolimus
gptkb:tenofovir_disoproxil_fumarate gptkb:tetrabenazine gptkb:olmesartan gptkb:Zetia gptkb:vandetanib gptkb:Esbriet gptkb:pemetrexed gptkb:DB01586 gptkb:Desvenlafaxine gptkb:Eszopiclone gptkb:DB08890 gptkb:Ranolazine gptkb:octreotide |
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
CHEMBL1201197
|